HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dominique Maciejewski-Lenoir Selected Research

3- (1H- tetrazol- 5- yl)- 1,4,5,6- tetrahydrocyclopentapyrazole

10/2013Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dominique Maciejewski-Lenoir Research Topics

Disease

3Atherosclerosis
10/2013 - 12/2006
3Flushing
10/2013 - 12/2006

Drug/Important Bio-Agent (IBA)

3Niacin (Nicotinic Acid)FDA LinkGeneric
10/2013 - 12/2006
2ProstaglandinsIBA
10/2013 - 12/2006
1LipidsIBA
10/2013
13- (1H- tetrazol- 5- yl)- 1,4,5,6- tetrahydrocyclopentapyrazoleIBA
10/2013
1Prostaglandin D2IBA
06/2007
1Mitogen-Activated Protein KinasesIBA
06/2007
1HDL CholesterolIBA
06/2007
1pyrazoleIBA
06/2007
1Prostaglandins DIBA
12/2006